![](/img/cover-not-exists.png)
2124 POSTER Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial
A. Chan, V. Ganju, D. Becquart, P.F. Conte, L. Petruzelka, O. Perrot, G. Villanova, N. Tubiana-MathieuVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70886-8
File:
PDF, 78 KB
english, 2007